Table 5.

Clinical stage I and duration.

	1–12 months	1–5 years	5–10 years	>10 years
Type I	0	0	0	0
Type II	4 (3.0%)	0	2 (1.5%)	6 (4.5%)
Type III	4 (3.0%)	0	2 (1.5%)	6 (4.5%)
Type IV	14 (10.6%)	26 (19.6%)	2 (1.5%)	2 (1.5%)
Type V	10 (7.5%)	24 (18.18%)	8 (6.0%)	0
Combined	2 (1.5%)	12 (9.0%)	4 (3.0%)	4 (3.0%)

χ ² = 53.504; p < 0.001 VHS.